Rhythm Pharmaceuticals (RYTM) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to -$52.9 million.
- Rhythm Pharmaceuticals' Profit After Tax fell 2122.55% to -$52.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$192.3 million, marking a year-over-year increase of 2571.62%. This contributed to the annual value of -$260.6 million for FY2024, which is 4111.16% down from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Profit After Tax stood at -$52.9 million for Q3 2025, which was down 2122.55% from -$46.6 million recorded in Q2 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Profit After Tax peaked at $65.8 million during Q1 2021, and registered a low of -$141.4 million during Q1 2024.
- For the 5-year period, Rhythm Pharmaceuticals' Profit After Tax averaged around -$44.1 million, with its median value being -$44.1 million (2021).
- As far as peak fluctuations go, Rhythm Pharmaceuticals' Profit After Tax skyrocketed by 29247.16% in 2021, and later plummeted by 18024.21% in 2022.
- Rhythm Pharmaceuticals' Profit After Tax (Quarter) stood at -$42.9 million in 2021, then rose by 0.87% to -$42.5 million in 2022, then increased by 2.02% to -$41.6 million in 2023, then fell by 3.98% to -$43.3 million in 2024, then decreased by 22.2% to -$52.9 million in 2025.
- Its last three reported values are -$52.9 million in Q3 2025, -$46.6 million for Q2 2025, and -$49.5 million during Q1 2025.